Lektalgin
General properties
Anti-inflammatory and anti-rheumatic products, non-steroids. Acetic acid derivatives and related substances.
- Short-term management of moderate to severe acute post-operative pain.
Hypersensitivity to ketorolac or any of the inactive ingredients or other NSAIDs.
Active peptic ulcer, any recent history of gastrointestinal bleeding, ulceration or perforation or history of gastrointestinal bleeding.
Active or a history of gastrointestinal bleeding or cerebrovascular bleeding. High haemorrhagic risk or incomplete haemostasis, bleeding diathesis.
Severe renal impairment (serum creatinine >160 µmol/L).
The risk of renal failure due to dehydration.
Coagulation disorders.
Patients on antiplatelet drugs (acetylsalicylic acid), anti-coagulants including warfarin and low dose heparin (2500-5000 units twelve hourly).
Severe heart failure, hepatic failure.
Patients with allergic reactions such as asthma, rhinitis, angioedema or urticaria to other prostaglandin synthesis inhibitors.
History of bronchial asthma, bronchospasm, nasal polyps, angioedema.
The drug is contraindicated in labour.
Concurrent treatment with other NSAIDs including selective cyclooxygenase inhibitors, acetylsalicylic acid, warfarin, pentoxifylline, probenecid or lithium salts.
Hypersensitivity to acetylsalicylic acid or other prostaglandin synthesis inhibitors (severe anaphylactic-like reactions have been observed in such patients).
Ketorolac is contraindicated as analgesia before surgery and intra-operatively.
Ketorolac is contraindicated for epidural or intrathecal administration.
Pharmaceutical characteristics
Clear yellowish liquid.
Store in original package at temperature not exceeding 25 °С.
Keep away from children.
